Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

BofA analyst Michael Ryskin raised the firm’s price target on Quest Diagnostics (DGX) to $198 from $190 and keeps a Buy rating on the shares.

Susquehanna analyst Charles Minervino lowered the firm’s price target on Bloom Energy (BE) to $26 from $33 and keeps a Positive rating on the ...

Analysts have taken out their red pens and given Intuit’s stock a polite scolding. Oppenheimer slashed its price target from ...